4,4-Dimethyl-1-[(3,4-methylenedioxy)phenyl]-1-penten-3-ol
CAS: 49763-96-4
Ref. 3D-FS27881
1g | 454.00 € | ||
2g | 717.00 € | ||
100mg | 137.00 € | ||
250mg | 218.00 € | ||
500mg | 350.00 € |
Product Information
- 1-(1,3-Benzodioxol-5yl)-4,4-dimethyl-1-penten-3-olStiripentol
- (1E)-1-(1,3-benzodioxol-5-yl)-4,4-dimethylpent-1-en-3-ol
- 1-(1,3-Benzodioxol-5-Yl)-4,4-Dimethylpent-1-En-3-Ol
- 1-(1,3-Benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol
- 1-Penten-3-ol, 1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-
- 256-480-9
- 4,4-Dimethyl-1-(3,4-methylenedioxyphenyl)-1-penten-3-ol
- Bcx 2600
- Diacomit
4,4-Dimethyl-1-[(3,4-methylenedioxy)phenyl]-1-penten-3-ol is a drug that has been used in the treatment of Dravet syndrome. This drug is also known as 3,4-methylenedioxyphenylacetone. It is a competitive inhibitor of the enzyme citrate synthase and inhibits the conversion of acetate to citrate. The effect of 4,4-dimethyl-1-[(3,4-methylenedioxy)phenyl]-1-penten-3-ol on sodium citrate concentrations is concentration dependent and results in an increase in plasma sodium concentrations with prolonged administration. Other drugs that are metabolized by the cytochrome P450 system may interact with 4,4-dimethyl-1-[(3,4 methylenedioxy)phenyl]-1 penten 3 ol and lead to increased levels of these drugs in the blood.
Chemical properties
Technical inquiry about: 3D-FS27881 4,4-Dimethyl-1-[(3,4-methylenedioxy)phenyl]-1-penten-3-ol
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.